Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Pegaptanib> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Pegaptanib abstract "Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). It was discovered by NeXstar Pharmaceuticals and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States. Outside the US pegaptanib is marketed by Pfizer. Approval was granted by the U.S. Food and Drug Administration (FDA) in December 2004.".
- Pegaptanib atcPrefix "S01".
- Pegaptanib atcSuffix "LA03".
- Pegaptanib casNumber "222716-86-1".
- Pegaptanib drugbank "DB04895".
- Pegaptanib fdaUniiCode "2H1PA8H1EN".
- Pegaptanib iupacName "RNA, ((2'-deoxy-2'-fluoro)C-Gm-Gm-A-A-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'-fluoro)C-Am-Gm-(2'-deoxy-2'-fluoro)U-Gm-Am-Am-(2'-deoxy-2'-fluoro)U-Gm-(2'-deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)U-(2'-deoxy-2'fluoro)U-Am-(2'-deoxy-2'-fluoro)U-Am-(2'-deoxy-2'-fluoro)C-Am-(2'-deoxy-2'-fluoro)U-(2'deoxy-2'-fluoro)C-(2'-deoxy-2'-fluoro)C-Gm-(3'→3')-dT), 5'-ester with α,α'-[4,12-dioxo-6[[[5-(phosphoonoxy)pentyl]amino]carbonyl]-3,13-dioxa-5,11-diaza-1,15-pentadecanediyl]bis[ω-methoxypoly(oxy-1,2-ethanediyl)], sodium salt".
- Pegaptanib thumbnail Pegaptanib_sodium_skeletal.svg?width=300.
- Pegaptanib wikiPageID "8313425".
- Pegaptanib wikiPageRevisionID "591684915".
- Pegaptanib atcPrefix "S01".
- Pegaptanib atcSuffix "LA03".
- Pegaptanib casNumber "222716".
- Pegaptanib chemicalFormula "C294H342F13N107Na28O188P28[C2H4O]2n".
- Pegaptanib chemspiderid "NA".
- Pegaptanib drugName "Pegaptanib sodium".
- Pegaptanib drugbank "DB04895".
- Pegaptanib eliminationHalfLife "864000.0".
- Pegaptanib hasPhotoCollection Pegaptanib.
- Pegaptanib iupacName "RNA, , 5'-ester with α,α'-[4,12-dioxo-6[[[5-pentyl]amino]carbonyl]-3,13-dioxa-5,11-diaza-1,15-pentadecanediyl]bis[ω-methoxypoly], sodium salt".
- Pegaptanib legalUs "Rx-only".
- Pegaptanib medlineplus "a607057".
- Pegaptanib molecularWeight "~50 kDa".
- Pegaptanib pregnancyUs "B".
- Pegaptanib routesOfAdministration "Intravitreal injection".
- Pegaptanib tradename "Macugen".
- Pegaptanib unii "2".
- Pegaptanib verifiedrevid "464197562".
- Pegaptanib watchedfields "changed".
- Pegaptanib width "300".
- Pegaptanib subject Category:Gilead_Sciences.
- Pegaptanib subject Category:Ophthalmology_drugs.
- Pegaptanib subject Category:Pfizer.
- Pegaptanib type Agent114778436.
- Pegaptanib type CausalAgent100007347.
- Pegaptanib type Drug103247620.
- Pegaptanib type Matter100020827.
- Pegaptanib type OphthalmologyDrugs.
- Pegaptanib type PhysicalEntity100001930.
- Pegaptanib type Substance100020090.
- Pegaptanib type Drug.
- Pegaptanib type DrugProduct.
- Pegaptanib type FunctionalSubstance.
- Pegaptanib comment "Pegaptanib sodium injection (brand name Macugen) is an anti-angiogenic medicine for the treatment of neovascular (wet) age-related macular degeneration (AMD). It was discovered by NeXstar Pharmaceuticals and licensed in 2000 to EyeTech Pharmaceuticals, now OSI Pharmaceuticals, for late stage development and marketing in the United States. Outside the US pegaptanib is marketed by Pfizer. Approval was granted by the U.S. Food and Drug Administration (FDA) in December 2004.".
- Pegaptanib label "Pegaptanib".
- Pegaptanib label "Pegaptanib".
- Pegaptanib label "Pegaptanib".
- Pegaptanib label "Pegaptanib".
- Pegaptanib sameAs Pegaptanib.
- Pegaptanib sameAs Pegaptanib.
- Pegaptanib sameAs Pegaptanib.
- Pegaptanib sameAs m.0hqw6kx.
- Pegaptanib sameAs Q409935.
- Pegaptanib sameAs Q409935.
- Pegaptanib sameAs DB04895.
- Pegaptanib sameAs Pegaptanib.
- Pegaptanib wasDerivedFrom Pegaptanib?oldid=591684915.
- Pegaptanib depiction Pegaptanib_sodium_skeletal.svg.
- Pegaptanib isPrimaryTopicOf Pegaptanib.
- Pegaptanib name "Pegaptanib sodium".